In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
Maciej Banach
Speaker
Maciej Banach
Maciej Banach Maciej Banach

Medical University of Lodz, Lodz (Poland)

Specialities : Risk Factors and Prevention , Pharmacology and Pharmacotherapy, Hypertension, Cardiovascular Disease in Women, Pregnancy and Cardiovascular Disease

Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He is a President of Polish Mother's Memorial Hospital - Research Institute (PMMHRI) in Lodz, Head of Cardiovascular Research Centre at University of Zielona Gora, full Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI and Head of Department of Hypertension at the MUL, Lodz, Poland. He is member of the Executive Committee of European Atherosclerosis Society (EAS) working as an Advisor in Matters related to European Union Relations/Contacts, and the International Atherosclerosis Society (IAS) Regional Federation Executive Committee Member for Europe. He is a Founder and Head of the Polish Lipid Association (PoLA), the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, and the International Lipid Expert Panel (ILEP). Prof. Banach has published over 1000 papers (number of citations >26.000, IH>70).

48 presentations from this speaker

Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer.

Event : ESC Congress 2019

  • Session : Cancer and the heart: novel insights from bench to bedside
  • Speaker : M Banach (Lodz,PL)

Association between familial hypercholesterolemia and telomere length in US adults

Event : ESC Congress 2018

  • Session : Preventive cardiology, lipids
  • Speaker : M Banach (Lodz,PL)

Combined nutraceuticals.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Beyond medicines. Evidence of particular foodstuff for cardiovascular prevention and management
  • Speaker : M Banach (Lodz,PL)

From science to practice: a patient case.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : The power of synergy.
  • Speaker : M Banach (Lodz,PL)
  • Sponsored by Krka, d. d., Novo mesto

Higher dietary acids load is associated with higher likelihood of peripheral arterial disease among american adults

Event : ESC Congress 2018

  • Session : Peripheral vascular and cerebrovascular disease: pathophysiology
  • Speaker : M Banach (Lodz,PL)

Red rice yeast.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Beyond medicines. Evidence of particular foodstuff for cardiovascular prevention and management
  • Speaker : M Banach (Lodz,PL)

Prevalence of familial hypercholesterolemia in Poland in the LIPIDOGRAM2004 and 2006 population-based surveys.

Event : ESC Congress 2017

  • Session : Lipids, obesity and metabolic syndrome
  • Speaker : M Banach (Lodz,PL)

Statin side effects from the muscle to the liver and the brain

Event : ESC Congress 2017

  • Session : Problems with statin treatment
  • Speaker : M Banach (Lodz,PL)

Telomere length is associated with cardiometabolic factors in US adults.

Event : ESC Congress 2017

  • Session : Cardiovascular risk factors in general population
  • Speaker : M Banach (Lodz,PL)

Telomere length is associated with serum antioxidant levels in US adults

Event : ESC Congress 2017

  • Session : From telomere length to machine learning - News in risk prediction
  • Speaker : M Banach (Lodz,PL)

Does statin therpy unfavourably influence healthy lifestyle? the results of the lipidogram survey

Event : ESC Congress 2015

  • Session : Diet and exercise: prevention begins here
  • Speaker : M Banach (Lodz,PL)

Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials

Event : ESC Congress 2015

  • Session : Treatment of hypercholesterolemia. A vision to the future
  • Speaker : M Banach (Lodz,PL)

Impact of comorbidities (focus on chronic kidney disease, diabetes,…).

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Update on Lipid Lowering Therapy part 1: Why are some patients more difficult to treat with statins than others?
  • Speaker : M Banach (Lodz,PL)

Tibolone can decrease Lipoprotein(a) concentrations in postmenopausal women: a systematic review and meta-analysis of controlled trials

Event : ESC Congress 2015

  • Session : Treatment strategies and adherence: can we decrease risk?
  • Speaker : M Banach (Lodz,PL)

Controversial cases in lipid management: conclusion and general take home message.

Event : ESC Congress 2014

  • Session : Controversial cases in lipid management
  • Speaker : M Banach (Lodz,PL)

Dysfunctional high-density lipoprotein as a diagnostic and therapeutic target.

Event : ESC Congress 2013

  • Session : The high-density lipoprotein story: waiting for a happy ending
  • Speaker : M Banach (Lodz,PL)

REGARDS: Optimal blood pressure levels in elderly persons in the reasons for geographic and racial differences in stroke (REGARDS) cohort study

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : M Banach (Lodz,PL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are